168 related articles for article (PubMed ID: 22157707)
1. Profiling of autoantibodies in IgA nephropathy, an integrative antibiomics approach.
Sigdel TK; Woo SH; Dai H; Khatri P; Li L; Myers B; Sarwal MM; Lafayette RA
Clin J Am Soc Nephrol; 2011 Dec; 6(12):2775-84. PubMed ID: 22157707
[TBL] [Abstract][Full Text] [Related]
2. Mapping novel immunogenic epitopes in IgA nephropathy.
Woo SH; Sigdel TK; Dinh VT; Vu MT; Sarwal MM; Lafayette RA
Clin J Am Soc Nephrol; 2015 Mar; 10(3):372-81. PubMed ID: 25542908
[TBL] [Abstract][Full Text] [Related]
3. A pilot and comparative study between pathological and serological levels of immunoglobulin and complement among three kinds of primary glomerulonephritis.
Dong J; Peng T; Gao J; Jia X; Yan G; Wang Y
BMC Immunol; 2018 Jun; 19(1):18. PubMed ID: 29925312
[TBL] [Abstract][Full Text] [Related]
4. Glomerular Immunodeposits of Patients with IgA Nephropathy Are Enriched for IgG Autoantibodies Specific for Galactose-Deficient IgA1.
Rizk DV; Saha MK; Hall S; Novak L; Brown R; Huang ZQ; Fatima H; Julian BA; Novak J
J Am Soc Nephrol; 2019 Oct; 30(10):2017-2026. PubMed ID: 31444275
[TBL] [Abstract][Full Text] [Related]
5. Phosphatidylethanolamine binding protein-4 (PEBP4) is increased in IgA nephropathy and is associated with IgA-positive B-cells in affected kidneys.
Taylor S; Pieri K; Nanni P; Tica J; Barratt J; Didangelos A
J Autoimmun; 2019 Dec; 105():102309. PubMed ID: 31402200
[TBL] [Abstract][Full Text] [Related]
6. Malignant hypertension in IgA nephropathy was not associated with background pathological phenotypes of glomerular lesions.
Jiang L; Zhang JJ; Lv JC; Liu G; Zou WZ; Zhao MH; Zhang H
Nephrol Dial Transplant; 2008 Dec; 23(12):3921-7. PubMed ID: 18603547
[TBL] [Abstract][Full Text] [Related]
7. Proliferative glomerulonephritis with monoclonal immunoglobulin G deposits complicated by immunoglobulin A nephropathy in the renal allograft.
Sawada A; Kawanishi K; Horita S; Koike J; Honda K; Ochi A; Komoda M; Tanaka Y; Unagami K; Okumi M; Shimizu T; Ishida H; Tanabe K; Nagashima Y; Nitta K
Nephrology (Carlton); 2016 Jul; 21 Suppl 1():48-52. PubMed ID: 26971743
[TBL] [Abstract][Full Text] [Related]
8. Characteristics of patients with coexisting IgA nephropathy and membranous nephropathy.
Chen P; Shi SF; Qu Z; Zhao N; Xie XF; Lv JC; Liu LJ; Zhang H
Ren Fail; 2018 Nov; 40(1):213-218. PubMed ID: 29619862
[TBL] [Abstract][Full Text] [Related]
9. Recurrent IgA nephropathy is predicted by altered glycosylated IgA, autoantibodies and soluble CD89 complexes.
Berthelot L; Robert T; Vuiblet V; Tabary T; Braconnier A; Dramé M; Toupance O; Rieu P; Monteiro RC; Touré F
Kidney Int; 2015 Oct; 88(4):815-22. PubMed ID: 26061544
[TBL] [Abstract][Full Text] [Related]
10. High serum IgA/C3 ratio better predicts a diagnosis of IgA nephropathy among primary glomerular nephropathy patients with proteinuria ≤ 1 g/d: an observational cross-sectional study.
Gong WY; Liu M; Luo D; Liu FN; Yin LH; Li YQ; Zhang J; Peng H
BMC Nephrol; 2019 Apr; 20(1):150. PubMed ID: 31039758
[TBL] [Abstract][Full Text] [Related]
11. Circulating IgA, IgG, and IgM class antibody against Haemophilus parainfluenzae antigens in patients with IgA nephropathy.
Suzuki S; Nakatomi Y; Odani S; Sato H; Gejyo F; Arakawa M
Clin Exp Immunol; 1996 May; 104(2):306-11. PubMed ID: 8625525
[TBL] [Abstract][Full Text] [Related]
12. Autoantibodies targeting galactose-deficient IgA1 associate with progression of IgA nephropathy.
Berthoux F; Suzuki H; Thibaudin L; Yanagawa H; Maillard N; Mariat C; Tomino Y; Julian BA; Novak J
J Am Soc Nephrol; 2012 Sep; 23(9):1579-87. PubMed ID: 22904352
[TBL] [Abstract][Full Text] [Related]
13. Gluten sensitivity in patients with IgA nephropathy.
Smerud HK; Fellström B; Hällgren R; Osagie S; Venge P; Kristjánsson G
Nephrol Dial Transplant; 2009 Aug; 24(8):2476-81. PubMed ID: 19332868
[TBL] [Abstract][Full Text] [Related]
14. Aberrantly glycosylated IgA1 in IgA nephropathy patients is recognized by IgG antibodies with restricted heterogeneity.
Suzuki H; Fan R; Zhang Z; Brown R; Hall S; Julian BA; Chatham WW; Suzuki Y; Wyatt RJ; Moldoveanu Z; Lee JY; Robinson J; Tomana M; Tomino Y; Mestecky J; Novak J
J Clin Invest; 2009 Jun; 119(6):1668-77. PubMed ID: 19478457
[TBL] [Abstract][Full Text] [Related]
15. [Role of IgG antibody to galactose-deficient IgA1 in children with IgA nephropathy].
Zhou N; Zhang H; Liu XR; Sun Q; Meng Q; Chen Z; Shen Y
Zhonghua Er Ke Za Zhi; 2017 Sep; 55(9):663-667. PubMed ID: 28881511
[No Abstract] [Full Text] [Related]
16. Elevation of serum von Willebrand factor and anti-endothelial cell antibodies in patients with immunoglobulin A nephropathy are associated with intrarenal arterial lesions.
Zhang JJ; Jiang L; Liu G; Wang SX; Zou WZ; Zhang H; Zhao MH
Nephrology (Carlton); 2008 Dec; 13(8):712-20. PubMed ID: 18771467
[TBL] [Abstract][Full Text] [Related]
17. Patients with IgA nephropathy respond strongly through production of IgA with low avidity against Staphylococcus aureus.
Shimizu Y; Seki M; Kaneko S; Hagiwara M; Yoh K; Yamagata K; Koyama A
Contrib Nephrol; 2007; 157():139-43. PubMed ID: 17495452
[TBL] [Abstract][Full Text] [Related]
18. Prognostic Value of Serum Biomarkers of Autoimmunity for Recurrence of IgA Nephropathy after Kidney Transplantation.
Berthoux F; Suzuki H; Mohey H; Maillard N; Mariat C; Novak J; Julian BA
J Am Soc Nephrol; 2017 Jun; 28(6):1943-1950. PubMed ID: 28255003
[TBL] [Abstract][Full Text] [Related]
19. Serum immunoglobulin G provides early risk prediction in immunoglobulin A nephropathy.
Liu D; You J; Liu Y; Tang X; Tan X; Xia M; Wu L; Chen G; He L; Zhu X; Liu H
Int Immunopharmacol; 2019 Jan; 66():13-18. PubMed ID: 30415190
[TBL] [Abstract][Full Text] [Related]
20. CDR3 sequences in IgA nephropathy are shorter and exhibit reduced diversity.
Zhang X; Zeng J; Tong Y; Zhang L; Lu X; Zhu S; Li Z
FEBS Open Bio; 2020 Dec; 10(12):2702-2711. PubMed ID: 33067920
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
